Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
DCW Limited (DCW.NS)
Mumbai, MA, IN
DCW Limited is a prominent Indian manufacturer specializing in heavy chemicals. Its extensive operations are strategically segmented across various divisions, including Soda Ash, Caustic Soda, Polyvinyl Chloride (PVC), SIOP, and Chlorinated Polyvinyl Chloride (C-PVC). The company's diverse product portfolio encompasses key chemicals such as caustic soda, liquid chlorine, hydrochloric acid, synthetic rutile, trichloroethylene, both synthetic and yellow iron oxides, ferric chloride, utox, polyvinyl chloride, soda ash, and sodium and ammonium bicarbonate. In addition to serving the domestic market, DCW actively exports its manufactured goods to international clients. With its origins dating back to 1925, the enterprise was originally known as Dhrangadhra Chemical Works Limited. Today, it maintains its corporate headquarters in Mumbai, India.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -5.26% | -8.54% | +5.62% | -10.97% | -32.04% | -19.35% | -37.31% | -0.82% | +37.26% | +55.66% | +2,526.26% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%+7.2% ★ Q1'26: +13.2% (vs Q1'25)
-
EPS growth Chemicals: +11.7%+58.3% ★ Q1'26: +56.4% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%+3.8% ★ Q1'26: +12.4% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%+5.5% Q1'26: +6.3% (vs Q1'25)
-
ROIC Chemicals: +3.4%+6.6% ★ Q1'26: +8.4% (vs Q1'25)
-
Share dilution Chemicals: +0.0%+0.5% Q1'26: +1.6% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×1.31× ★ Q1'26: 1.12× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 1996 actual |
Mar 1997 actual |
Mar 1998 actual |
Mar 2013 actual |
Mar 2014 actual |
Mar 2015 actual |
|---|---|---|---|---|---|---|
| Revenue |
4.23B
est.
|
3.45B
est.
|
3.86B
est.
|
13.28B
est: 14.53B (-8.6%)
|
13.26B
est: 34.95B (-62.1%)
|
12.54B
est: 85.35B (-85.3%)
|
| EBITDA |
563.86M
est.
|
-58.55M
est.
|
503.76M
est.
|
2.49B
est: -250.45M (+1,095.8%)
|
1.30B
est: 4.54B (-71.3%)
|
619.34M
est: 11.43B (-94.6%)
|
| EBIT |
368.66M
est.
|
262.57M
est.
|
329.36M
est.
|
1.97B
est: 1.24B (+58.4%)
|
746.31M
est: 4.64B (-83.9%)
|
99.33M
est: 7.47B (-98.7%)
|
| Net Income |
1.77B
est.
|
24.46M
est.
|
1.06B
est.
|
1.05B
est: 1.66B (-36.7%)
|
378.79M
est: 2.56B (-85.2%)
|
-59.22M
est: 1.51B (-103.9%)
|
| SGA |
328.58M
est.
|
267.94M
est.
|
299.46M
est.
|
372.07M
est: 1.13B (-67.0%)
|
425.48M
est: 2.18B (-80.4%)
|
444.46M
est: 6.66B (-93.3%)
|
| EPS |
6.02
est.
|
6.34
est.
|
7.32
est.
|
5.05
est: 5.61 (-9.9%)
|
1.81
est: 5.33 (-66.0%)
|
-0.28
est: 5.12 (-105.5%)
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-08 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR S&P Emerging Markets Small Cap ETF EWX | 0.01% | 51.1K | 0.65% |
| 2 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 151.0K | 0.39% |
| 3 | Dimensional - Emerging Markets Value ETF DFEV | 0.00% | 22.4K | 0.46% |
| 4 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 64.1K | 0.29% |
| 5 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 39.6K | 0.28% |
| 6 | Dimensional - Emerging Markets ex China Core Equity ETF DEXC | 0.00% | 230.00 | 0.56% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Ashish Pramodkumar Jain | Managing Director | 19M | male |
| Bakul Premchand Jain | MD & Executive Chairman | 15M | male |
| Vivek Shashichand Jain | MD & Executive Director | 15M | male |
| Amitabh Gupta | Chief Executive Officer | — | male |
| Saatvik Jain | President | — | male |
| Sonalika Jain | President | — | female |
| Sudarshan Ganapathy | Chief Operating Officer | — | male |
| Pradipto Mukherjee | Chief Financial Officer | — | male |
| Malti Bhindi Jain | President | — | female |
| Paulomi Jain | President | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for DCW.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
